Pediatric Heart Failure
Pediatric heart failure is a significant challenge in clinical practice, a global burden worldwide. Compared to adult population, heart failure in children has a variety of etiologies depending on the patients age. However, pediatric heart failure guidelines are still extrapolated from adult...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2021-03-01
|
Series: | Romanian Journal of Pediatrics |
Subjects: | |
Online Access: | https://rjp.com.ro/articles/2021.1/RJP_2021_1_EN_Art-05.pdf |
id |
doaj-1961cf770dd244928595432ec387b69f |
---|---|
record_format |
Article |
spelling |
doaj-1961cf770dd244928595432ec387b69f2021-09-02T18:59:26ZengAmaltea Medical Publishing HouseRomanian Journal of Pediatrics1454-03982069-61752021-03-01701263010.37897/RJP.2021.1.5Pediatric Heart Failure Iolanda Muntean0Asmaa Carla Barmou1Liliana Gozar2Amalia Fagarasan3“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Tg. Mures, Romania ; Clinic of Pediatric Cardiology, Emergency Institute of Cardiovascular Diseases and Transplantation, Tg. Mures, RomaniaClinic of Pediatric Cardiology, Emergency Institute of Cardiovascular Diseases and Transplantation, Tg. Mures, Romania“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Tg. Mures, Romania ; Clinic of Pediatric Cardiology, Emergency Institute of Cardiovascular Diseases and Transplantation, Tg. Mures, Romania“George Emil Palade” University of Medicine, Pharmacy, Science and Technology, Tg. Mures, Romania ; Clinic of Pediatric Cardiology, Emergency Institute of Cardiovascular Diseases and Transplantation, Tg. Mures, RomaniaPediatric heart failure is a significant challenge in clinical practice, a global burden worldwide. Compared to adult population, heart failure in children has a variety of etiologies depending on the patients age. However, pediatric heart failure guidelines are still extrapolated from adult population. In infants and children, the pharmacological treatment is based on angiotensin-converting enzyme inhibitors, beta-blockers, aldosterone receptors antagonists, and other diuretics in the presence of congestion, with a lower use of device therapy. In end-stage heart failure, as a bridge to transplantation or recovery, ventricular assist devices or different palliative surgical interventions are used nowadays.This review focuses on the most important causes, pathophysiological mechanisms, clinical manifestation and management of pediatric heart faliure based on recent guidelines. Furthermore, it emphasize the newer pharmaco-logical or non-pharmacological therapies that have been recently approved in pediatric population. https://rjp.com.ro/articles/2021.1/RJP_2021_1_EN_Art-05.pdfpediatric heart failureclinical managementpharmacological treatamentmechanical assist devicesheart transplant |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Iolanda Muntean Asmaa Carla Barmou Liliana Gozar Amalia Fagarasan |
spellingShingle |
Iolanda Muntean Asmaa Carla Barmou Liliana Gozar Amalia Fagarasan Pediatric Heart Failure Romanian Journal of Pediatrics pediatric heart failure clinical management pharmacological treatament mechanical assist devices heart transplant |
author_facet |
Iolanda Muntean Asmaa Carla Barmou Liliana Gozar Amalia Fagarasan |
author_sort |
Iolanda Muntean |
title |
Pediatric Heart Failure |
title_short |
Pediatric Heart Failure |
title_full |
Pediatric Heart Failure |
title_fullStr |
Pediatric Heart Failure |
title_full_unstemmed |
Pediatric Heart Failure |
title_sort |
pediatric heart failure |
publisher |
Amaltea Medical Publishing House |
series |
Romanian Journal of Pediatrics |
issn |
1454-0398 2069-6175 |
publishDate |
2021-03-01 |
description |
Pediatric heart failure is a significant challenge in clinical practice, a global burden worldwide. Compared to adult population, heart failure in children has a variety of etiologies depending on the patients age. However, pediatric heart failure guidelines are still extrapolated from adult population. In infants and children, the pharmacological treatment is based on angiotensin-converting enzyme inhibitors, beta-blockers, aldosterone receptors antagonists, and other diuretics in the presence of congestion, with a lower use of device therapy. In end-stage heart failure, as a bridge to transplantation or recovery, ventricular assist devices or different palliative surgical interventions are used nowadays.This review focuses on the most important causes, pathophysiological mechanisms, clinical manifestation and management of pediatric heart faliure based on recent guidelines. Furthermore, it emphasize the newer pharmaco-logical or non-pharmacological therapies that have been recently approved in pediatric population. |
topic |
pediatric heart failure clinical management pharmacological treatament mechanical assist devices heart transplant |
url |
https://rjp.com.ro/articles/2021.1/RJP_2021_1_EN_Art-05.pdf |
work_keys_str_mv |
AT iolandamuntean pediatricheartfailure AT asmaacarlabarmou pediatricheartfailure AT lilianagozar pediatricheartfailure AT amaliafagarasan pediatricheartfailure |
_version_ |
1721171165245865984 |